About John Ryans House at Jade Wellness
Services
Type of Care
Substance use treatment; Transitional housing, halfway house, or sober home
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Outpatient; Outpatient day treatment or partial hospitalization; Intensive outpatient treatment; Outpatient methadone/buprenorphine or naltrexone treatment; Regular outpatient treatment
Opioid Medications used in Treatment
Buprenorphine used in Treatment; Naltrexone used in Treatment
External Opioid Medications Source
In-network prescribing entity; Other contracted prescribing entity; No formal relationship with prescribing entity
Type of Alcohol Use Disorder Treatment
Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
External Source of Medications Used for Alcohol Use Disorder Treatment
In-network prescribing entity; Other contracted prescribing entity; No formal relationship with prescribing entity
Type of Opioid Treatment
Prescribes buprenorphine; Relapse prevention with naltrexone; Accepts clients using MAT but prescribed elsewhere; Lofexidine or Clonidine detoxification
Pharmacotherapies
Buprenorphine with naloxone; Buprenorphine without naloxone; Buprenorphine (extended-release, injectable); Naltrexone (oral); Naltrexone (extended-release, injectable); Clonidine; Medication for mental disorders; Non-nicotine smoking/tobacco cessation
Treatment Approaches
Contingency management/motivational incentives; Community reinforcement plus vouchers; Motivational interviewing; Relapse prevention; Telemedicine/telehealth therapy; 12-step facilitation
Facility Operation (e.g., Private, Public)
Private for-profit organization
License/Certification/Accreditation
State Substance use treatment agency
Payment/Insurance/Funding Accepted
Federal, or any government funding for substance use treatment programs; Medicaid; Cash or self-payment
Special Programs/Groups Offered
Young adults; Adult men; Clients who have experienced trauma
Assessment/Pre-treatment
Comprehensive mental health assessment; Comprehensive substance use assessment; Complete medical history/physical exam; Screening for tobacco use; Screening for substance use; Screening for mental disorders
Testing
Drug and alcohol oral fluid testing; Drug or alcohol urine screening
Transitional Services
Aftercare/continuing care; Discharge Planning; Naloxone and overdose education; Outcome follow-up after discharge
Recovery Support Services
Self-help groups; Housing services; Assistance with obtaining social services; Recovery coach; Mentoring/peer support; Employment counseling or training
Education and Counseling Services
HIV or AIDS education, counseling, or support; Hepatitis education, counseling, or support
Facility Smoking Policy
Smoking permitted in designated area
Age Groups Accepted
Young Adults; Adults; Seniors
Sex Accepted
Male
Facility Vaping Policy
Vaping permitted in designated area
Ancillary Services
Case management service; Social skills development; Transportation assistance; Suicide prevention services
Type of Care
Substance use treatment; Transitional housing, halfway house, or sober home
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Outpatient; Outpatient day treatment or partial hospitalization; Intensive outpatient treatment; Outpatient methadone/buprenorphine or naltrexone treatment; Regular outpatient treatment
Opioid Medications used in Treatment
Buprenorphine used in Treatment; Naltrexone used in Treatment
External Opioid Medications Source
In-network prescribing entity; Other contracted prescribing entity; No formal relationship with prescribing entity
Type of Alcohol Use Disorder Treatment
Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
External Source of Medications Used for Alcohol Use Disorder Treatment
In-network prescribing entity; Other contracted prescribing entity; No formal relationship with prescribing entity
Type of Opioid Treatment
Prescribes buprenorphine; Relapse prevention with naltrexone; Accepts clients using MAT but prescribed elsewhere; Lofexidine or Clonidine detoxification
Pharmacotherapies
Buprenorphine with naloxone; Buprenorphine without naloxone; Buprenorphine (extended-release, injectable); Naltrexone (oral); Naltrexone (extended-release, injectable); Clonidine; Medication for mental disorders; Non-nicotine smoking/tobacco cessation
Treatment Approaches
Contingency management/motivational incentives; Community reinforcement plus vouchers; Motivational interviewing; Relapse prevention; Telemedicine/telehealth therapy; 12-step facilitation
Facility Operation (e.g., Private, Public)
Private for-profit organization
License/Certification/Accreditation
State Substance use treatment agency
Payment/Insurance/Funding Accepted
Federal, or any government funding for substance use treatment programs; Medicaid; Cash or self-payment
Special Programs/Groups Offered
Young adults; Adult men; Clients who have experienced trauma
Assessment/Pre-treatment
Comprehensive mental health assessment; Comprehensive substance use assessment; Complete medical history/physical exam; Screening for tobacco use; Screening for substance use; Screening for mental disorders
Testing
Drug and alcohol oral fluid testing; Drug or alcohol urine screening
Transitional Services
Aftercare/continuing care; Discharge Planning; Naloxone and overdose education; Outcome follow-up after discharge
Recovery Support Services
Self-help groups; Housing services; Assistance with obtaining social services; Recovery coach; Mentoring/peer support; Employment counseling or training
Education and Counseling Services
HIV or AIDS education, counseling, or support; Hepatitis education, counseling, or support
Facility Smoking Policy
Smoking permitted in designated area
Age Groups Accepted
Young Adults; Adults; Seniors
Sex Accepted
Male
Facility Vaping Policy
Vaping permitted in designated area
Ancillary Services
Case management service; Social skills development; Transportation assistance; Suicide prevention services
